Shibata N, Hoshino N, Minouchi T, Yamaji A
Department of Hospital Pharmacy, Shiga University of Medical Science, Otsu, Japan.
Biol Pharm Bull. 1995 Oct;18(10):1423-9. doi: 10.1248/bpb.18.1423.
We constructed a nomogram for determining the optimal regimen of cyclosporine (CyA), based on physiological changes that occur during immunosuppressive therapy. The nomogram consists of a fixed model and a variable model. In the fixed model, the oral dose of CyA (D, mg/kg) is given by the multiple linear function of logarithmic CyA trough level (TL, ng/ml), the surrogate apparent total body clearance of CyA (CL/fsu, l/h/kg, being equal to D/TL/12), and the erythrocyte-to-plasma distribution ratio of CyA (CyA-EP), as defined by: D = 4.938 x log(TL) + 1.5037 x CL/fsu - 0.0326 x CyA-EP - 10.7156. In the variable model, the CL/fsu is given by the CyA-EP and the patient's intrinsic parameters (P1, P2), using a nonlinear equation: CL/fsu = P1 x exp(P2 x CyA-EP)/CyA-EP. An optimal CyA dose to maintain a desired trough level was calculated, and the validity of the nomogram was found satisfactory for clinical use. This offers a very concise and practical method for the therapeutic monitoring of CyA. Because the pharmacokinetics of CyA depends on physiological changes due to several disease states, and because the CyA-EP reflects the pharmacokinetics of CyA and the patient's disease state, the proposed nomogram is believed to provide an optimal dosage adjustment, taking physiological factors into consideration.
我们基于免疫抑制治疗期间发生的生理变化构建了一个用于确定环孢素(CyA)最佳用药方案的列线图。该列线图由固定模型和可变模型组成。在固定模型中,CyA的口服剂量(D,mg/kg)由CyA谷浓度(TL,ng/ml)的对数、CyA的替代表观总体清除率(CL/fsu,l/h/kg,等于D/TL/12)以及CyA的红细胞与血浆分布比(CyA-EP)的多元线性函数给出,定义为:D = 4.938 × log(TL) + 1.5037 × CL/fsu - 0.0326 × CyA-EP - 10.7156。在可变模型中,CL/fsu由CyA-EP和患者的内在参数(P1,P2)通过非线性方程给出:CL/fsu = P1 × exp(P2 × CyA-EP)/CyA-EP。计算出维持所需谷浓度的最佳CyA剂量,发现该列线图在临床应用中的有效性令人满意。这为CyA的治疗监测提供了一种非常简洁实用的方法。由于CyA的药代动力学取决于多种疾病状态引起的生理变化,并且由于CyA-EP反映了CyA的药代动力学和患者的疾病状态,因此认为所提出的列线图在考虑生理因素的情况下能够提供最佳的剂量调整。